Review of Nocturnal Cramps and Introduction of a Novel Topical Therapy

Joseph Renzulli, Ralph Lombardo, Jack Payne

Abstract


Nocturnal leg and foot cramps are reported by more than half of the U.S. population over age 50, with varying frequency, but of those reporting the ailment, up to 20% experience nightly episodes, with attendant sleep disruption which can exacerbate other medical conditions.   While there is a widespread belief, even among many clinicians, that hypohydration and electrolyte depletion from exercise are the primary causes of leg cramps, there is strong evidence that neither of these is a primary factor in either exercise-induced or nocturnal muscle cramping.  Many commonly used prescription drugs have an impact on muscle physiology and can cause or exacerbate cramps.  There is good evidence that the physiological and neurological impact of muscle fatigue, and associated changes in muscle biochemistry, including lactic acid accumulation, are one key factor in nocturnal cramping.  A new topical approach to the condition has shown early evidence of its potential to address nocturnal cramping, due to its demonstrated ability to increase oxygen availability and reduce lactic acid levels in muscle tissue.

Nocturnal cramps represent a common medical challenge in patients age 50 and up, with a higher incidence as individuals age(1).  Up to 60% of adults over 50 years of age report a history of night cramps, usually in the calf or thigh, but sometimes the foot.  Up to 20% of those experiencing nocturnal cramps have nightly episodes, which can be severe enough to warrant medical treatment.(2)  While nocturnal cramping is not as common in younger populations, 7% of children in one study had experienced at least one cramping episode within the prior 12 months.(3) 

Nocturnal cramping episodes vary in severity, but for many patients the experience is both painful and debilitating.  While the average duration of a nocturnal cramp is nine minutes, the initial event is frequently followed by recurrent episodes and residual pain that may last for up to one week.(4)  For many older patients, nocturnal cramping is a nightly experience, and the attendant sleep disruption can exacerbate other medical conditions, including a negative impact on immune response, cognitive ability, and cardiovascular health.(5,6,7)


Keywords


medical, medicine,research,pharmacology

Full Text:

PDF

References


Butler JV, Mulkerrin EC, O’Keefe ST; Nocturnal Cramps in Older People, Postgrad Med, 2002 78: 596-598

Allen RE, Kirby KA; Nocturnal Leg Cramps. American Fam. Physician, 2012 Aug, 86 (4), 350-355

Leung AK, Wong BE, Chan PY, Cho HY; Nocturnal Leg Cramps in Children: Incidence and Clinical Characteristics. J. Natl. Medical Assoc., 1999 June, (6), 329-332

Monderer RS, Wu WP, Thorpy MJ; Nocturnal Leg Cramps. Current Neurology and Neuroscience Reports, 2010 January, 10 (1), 53-59

Besedovsky L, Lange T, Born J; Sleep and Immune Function. Postgrad Med 2002 78: 596-598

Alhola D, Polo-Kantola P Sleep Deprivation—Impact on Cognitive Performance. Neuropsychiat Dis Treat 2007 Oct 3(5) 553-567

Colten HR, Altegant BM, eds. Sleep Deprivation: An Unmet Public Health Problem 2006 Washington DC: National Academic Press

Schwellnus MP, Nicol J, Laubscher R, Noakes TD. Serum electrolyte concentrations and hydration status are not associated with exercise associated muscle cramping (EAMC) in distance runners. Br J Sports Med. 2004;38(4):488–492.

Sulzer NU, Schwellnus MP, Noakes TD. Serum electrolytes in Ironman triathletes with exercise-associated muscle cramping. Med Sci Sports Exerc. 2005;37(7):1081–1085.

Baskol M, Ozbakir O, Coskun R, Baskol G, Saraymen R, Yucesoy M. The role of serum zinc and other factors on the prevalence of muscle cramps in non-alcoholic cirrhotic patients. J Clin Gastroenterol. 2004 Sept; 38(6):524–529

Tandburg E, Larsen PD, Karlsen K A Community-based Study of Sleep Disorders in Patients with Parkinson’s Disease Movement Disord 1998 13 (6) 895-899

Oboler SK, Prochazka AV, Meyer TJ. Leg symptoms in outpatient veterans. West J Med. 1991;155(3):256–259.

Sontag SJ, Wanner JN. The cause of leg cramps and knee pains; a hypothesis and effective treatment. Med Hypothesis 1988;25:35-41

Weiner IH, Weiner HL. Nocturnal Leg Muscle Cramps. JAMA 1980 244(20) 2332-2333.

Criggs RC. Episodic muscle spasms, cramps, and weakness. In: Fauci AS, Braunwald E, Isselbaucher KJ, et al, eds. Harrison’s Principles of Internal Medicine. 14th Ed. New York: McGraw Hill International, 1998: 119.

www.aan.com/Guidelines Sept 2016 AAN Summary of Evidence-based Guidelines: Drug Treatments for Symptoms of Muscle Cramps, Amer Acad of Neuro, St. Paul, MN

Dahle LO, Berg G, Hammar M, Hurtig M, Larsson L The effect of oral magnesium substitution on pregnancy-induced leg cramps. Am J Obstet. Gynecol. 1995 July; 173 (1) 175-180

Miller C, Mack GW, Knight KC, Hopkins JT, Draper DO, Fields PJ, Hunter I Reflex Inhibition of Electrically-induced Muscle Cramps in Hypohydrated Adults. Med Sci Sports Exerc 2010 May 42(5) 953-961

Miller KC Mack G Knight KL Electrolyte and plasma changes after ingestion pickle juice, water, and a common carbohydrate-electrolyte solution, J Ath Train 2009 Sep-Oct 44 (5) 454-461

Man-Son-Hing M Wells G Lau A, Quinine for nocturnal leg cramps; a meta-analysis including unpublished studies. J Gen Intern Med 1998 Sep 13 (9) 600-606

Achan J, Talisuna AO, Erhart A, Yeka A, Tibenderana JK, Beliraine FN, Rosenthal PJ, D’Allesandro U Quinine, an old world anti-malarial drug in a modern world; role in the treatment of malaria. Malaria Journal 2011 10:144

Drug Products for the Treatment and/or Prevention of Nocturnal Muscle Leg Cramps for Over-the Counter Human Use. 1994, August 22, FDA Final Rule, Federal Register, 59 (161) 43234

Drug Products Containing Quinine; Enforcement Action Dates, 2006, December 15, FDA Notice, Federal Register, 71 (241) 75557-75560

Derbis, J Serious Risks Associated with Using Quinine to Prevent or Treat Nocturnal Leg Cramps, 2012 Sep FDA News For Health Professionals, USFDA

Quinine-containing beverages may cause health problems. German Federal Institute for Risk Assessment (BfR) Health Assessment No. 020, 2008

Briggs GG, Freeman RK, Yaffe SJ; "Drugs in Pregnancy and Lactation. 7th ed." 2005 Philadelphia, PA: Lippincott Williams & Wilkins

Valiyil R, Christopher-Stine L; “Drug-related Myopathies of Which the Clinician Should Be Aware” Current Rheumatology Reports: June 2010, Volume 12, Issue 3, pp 213–220.

Fardet L, MD, Ph; Nazareth I, MD, PhD, Petersen I, PhD; “Association Between Long-term Quinine Exposure and All-Cause Mortality” JAMA. 2017;317(18):1907-1909. doi:10.1001/jama.2017.2332

Street, D., Bangsbo, J., & Juel, C. (2001). Interstitial pH in human skeletal muscle during and after dynamic graded exercise. J Physiol, 537(Pt 3), 993-998. (21)

Beers MH, Ouslander JG, Rollingher I, et al. Explicit criteria for determining inappropriate medication use in nursing home residents. UCLA Division of Geriatric Medicine. Arch Intern Med 1991;151:1825-32.

Bellar D. Report on Theraworx ActiveTM and muscle oxygenation and blood flow. Lafayette, LA.: University of Louisiana at Lafayette; 2017:1-8.

Wilson JM, Lowery, R.P., Sharp, M. & Wallace, W. . The Effects of the application of Theraworx Active on fatigue resistance, and blood lactate in resistance trained men: A Preliminary Report Tampa, FL.: Applied Science and Performance Institute; 2017:1-4.

Davidson C. J., et al. Rat tendon morphologic and functional changes resulting from soft tissue mobilization. Med Sci Sports Exerc. 1997; 9:313–319 [PubMed]

Gehlsen G. M., Ganion L. R., Helfst R. Fibroblast responses to variation in soft tissue mobilization pressure. Med Sci Sports Exerc. 1999; 31:531–535 [PubMed]




DOI: http://dx.doi.org/10.18103/imr.v3i8.529

Refbacks

  • There are currently no refbacks.
Copyright 2016. All rights reserved.